| 25823534
|
Dipeptidyl peptidase-4 inhibitor improves cardiac function by attenuating adverse cardiac remodelling in rats with chronic myocardial infarction. |
Exp Physiol |
2015 |
Inthachai T;Lekawanvijit S;Kumfu S;Apaijai N;Pongkan W;Chattipakorn SC;Chattipakorn N |
View
More |
| 27044778
|
Effects of dipeptidyl peptidase-4 inhibitor in insulin-resistant rats with myocardial infarction. |
J Endocrinol |
2016 |
Apaijai N;Inthachai T;Lekawanvijit S;Chattipakorn SC;Chattipakorn N |
View
More |
| 32803534
|
Efficacy and tolerability of DPP4 inhibitor, teneligliptin, on autonomic and peripheral neuropathy in type 2 diabetes: an open label, pilot study. |
Neurol Sci |
2021 |
Syngle A;Chahal S;Vohra K |
View
More |
| 35143044
|
IL-33 prevents the enhancement of AP-N, DPP4, and ACE2 expression induced by rhinovirus HRV16 in the human lung endothelium-potential implications for coronaviral airway infections. |
Allergy |
2022 |
Gulbas I;Gajewski A;Gawrysiak M;Szewczyk R;Likonska A;Michlewska S;Kowalski ML;Chalubinski M |
View
More |
